Treatment of Alzheimer's disease; current status and new perspectives
Top Cited Papers
- 1 September 2003
- journal article
- Published by Elsevier in The Lancet Neurology
- Vol. 2 (9) , 539-547
- https://doi.org/10.1016/s1474-4422(03)00502-7
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 2002
- Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with DonepezilCurrent Medical Research and Opinion, 2002
- Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase InhibitorsClinical Pharmacokinetics, 2002
- Towards Alzheimer's β-Amyloid VaccinationBiologicals, 2001
- GalantamineDrugs, 2000
- Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal DepletionJournal of Biological Chemistry, 1999
- Cholinesterase Inhibitors in the Treatment of Alzheimer??s DiseaseDrug Safety, 1998
- Lack of apolipoprotein E dramatically reduces amyloid β-peptide depositionNature Genetics, 1997
- Nicotinic System Involvement in Alzheimer??s and Parkinson??s DiseasesDrugs & Aging, 1997
- Treatment strategies for Alzheimer's diseaseThe Lancet, 1992